John is a Partner at Innosight and healthcare practice leader. He works with clients to design new strategies for long-term growth, architect resource allocation, build innovation capabilities, define new operating models, and manage enterprise-wide transformation. John also brings significant M&A advisory experience, from initial identification, to transaction support, to post-merger integration.
In healthcare, John has served executive teams of leading institutions across the value chain, including payors, providers, medical device, pharma / biotech, suppliers, and health information technology. Recently, his work focuses on how payors and providers can better collaborate to catalyze new care delivery models, new economic models, and better consumer experiences – both physical and digital.
Beyond healthcare, John has worked with leading global companies across a range of industries, including Automotive, Defense, and Energy. His work has focused on how cyclical, capital intensive firms can evolve their core business models and drive new growth simultaneously.
Prior to joining Innosight, John was with the Health and Life Sciences practice of Oliver Wyman, where he developed product and portfolio strategies for bio-pharma clients and worked with leading health insurance companies to catalyze business model transformation, from fee-for-service to fee-for-value constructs. Before Oliver Wyman, John advised a senior executive group at Genzyme, a leading biotech company headquartered in Cambridge, MA. Earlier in his career, John lead a team developing healthcare delivery integration strategies while at ICF International, a management consulting firm in Washington, D.C. John has also leveraged his experience in public health, working with governments and non-profit foundations to develop strategies that increase outcomes, affordability and access.
John holds a B.A. with honors in Economics, Government, and Philosophy from Wesleyan University.
“After the Breakups: Big Payers Find Vertical Love in New Faces”